Related Experiment Video
Updated: Jul 8, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: July 19, 2024
Clinical and sociodemographic characteristics of metabolic dysfunction-associated fatty liver subtypes in Malaysia
Kim Sui Wan1, Wah Kheong Chan2, Muhammad Fadhli Mohd Yusoff3
1Institute for Public Health, National Institutes of Health Malaysia, Setia Alam, Shah Alam, 40170, Selangor, Malaysia. kimsui@moh.gov.my.
Abstract:
We aimed to describe the sociodemographic and clinical characteristics of subtypes of metabolic dysfunction-associated fatty liver disease (MAFLD) in Malaysia. Adults with MAFLD were identified from a 2023 nationwide community-based cross-sectional study. Three mutually exclusive MAFLD subtypes were classified first by diabetes status (diabetic MAFLD), then by ≥ 2 metabolic dysfunctions (metabolic dysfunction MAFLD), and finally by overweight/obesity with < 2 metabolic dysfunctions (overweight MAFLD). Among 309 respondents with MAFLD, the mean age was 46.8 ± 14.8 years, with a balanced sex distribution, and most were Malay (63.8%) and married or living with a partner (71.8%). The diabetic MAFLD subtype was characterised by older age, Indian ethnicity, and a higher proportion of divorced or widowed individuals, whereas younger adults were predominantly represented in the metabolic dysfunction subtype. Metabolic syndrome, hypertension, and raised total cholesterol were more common in the metabolic dysfunction subtype. The diabetic subtype had the highest waist circumference, blood pressure, triglycerides, glycosylated haemoglobin A1c, and fasting blood glucose. A higher proportion (22.7%) of the diabetic subtype had moderate or high risks of advanced liver fibrosis, compared to metabolic dysfunction (8.8%) and overweight (0.0%) subtypes, P = 0.002. Around 57.6% of the diabetic MAFLD subtype had a high 10-year cardiovascular risk compared to 25.8% and 10.0% in the metabolic dysfunction and overweight subtypes, respectively, P < 0.001. Individuals with diabetes, metabolic dysfunction, and overweight MAFLD subtypes in Malaysia had different sociodemographic characteristics and clinical profiles. MAFLD subtypes may be used for risk stratification, and individualised treatment may be considered for different subtypes.
Related Concept Videos
Type II Diabetes I: Introduction
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Diabetes: Symptoms, Diagnosis, and Complications
